Switch to:
More From Other Websites
After Salix acquisition, Valeant receives FDA approval for IBS-D drug May 27 2015
Salix Announces FDA Approval of Xifaxan® 550 mg for the Treatment of IBS-D (Irritable Bowel... May 27 2015
Salix Announces FDA Approval of Xifaxan® 550 mg for the Treatment of IBS-D (Irritable Bowel... May 27 2015
Salix Announces FDA Approval of Xifaxan® 550 mg for the Treatment of IBS-D (Irritable Bowel... May 27 2015
FDA approves Actavis, Valeant drugs for irritable bowel syndrome May 27 2015
Actavis PLC (ACT), Pfizer Inc. (PFE) Among the Most Popular Healthcare Stocks of Billionaire... May 27 2015
Some Hedge Fund ETFs Love Healthcare Stocks May 27 2015
5 most popular health-care stocks among hedge funds May 26 2015
5 Most Popular Healthcare Stocks Among Hedge Funds May 26 2015
5 Drugs That Could Be Summer Blockbusters May 26 2015
Overheard: ‘Bubble’ Talk Won’t Slow Health Care Merger Pace May 25 2015
Overheard May 25 2015
'Bubble' Talk Won't Slow Health Care Merger Pace May 25 2015
Pharming and Cytobioteck Announce Distribution Agreement for Ruconest May 25 2015
VIDEO: 10 Growth Stocks in 10 Minutes May 23 2015
The 5 Most Controversial Trades Of 2015 From Ackman To Gross And Gundlach May 22 2015
The 5 Most Controversial Trades Of 2015 From Ackman To Gross And Gundlach May 22 2015
5 Investments That Show John Paulson Knows How to Play M&A May 22 2015
Valeant CEO: Healthcare Sector A 'Bit Of A Bubble' May 22 2015
A Look at the Canadian Economy, Stock ETFs May 22 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK